year
111Category: | Intermediates/Pharmaceutical intermediates |
|
|
CAS NO: | 5875-06-9 | ||
EC NO: | 227-541-7 | ||
Molecular Formula: | C16H27ClN2O3 | ||
Molecular Weight: | 330.8502 | ||
Specification: | |||
InChI: | InChI=1/C16H26N2O3.ClH/c1-4-10-20-15-8-7-13(12-14(15)17)16(19)21-11-9-18(5-2)6-3;/h7-8,12H,4-6,9-11,17H2,1-3H3;1H | ||
Product description: Proparacaine HCl is a voltage-gated sodium channels antagonist with ED50 of 3.4 mM.Quality confirmed by NMR & HPLC. See customer reviews, validations & product citations. Pharmacologic study revealed it to be potent and of low acute and subacute toxicity, well tolerated by most mucous membranes and of a low sensitizing index in man. Like other local anesthetics, pramoxine decreases the permeability of neuronal membranes to sodium ions, blocking both initiation and conduction of nerve impulses. Depolarization and repolarization of excitable neural membranes is thus inhibited, leading to numbness. Proparacaine HCl is a voltage-gated sodium channels antagonist with ED50 of 3.4 mM.Quality confirmed by NMR & HPLC. See customer reviews, validations & product citations. Proparacaine Hydrochloride Ophthalmic Solution USP, 0.5% is a local anesthetic for ophthalmic instillation. Each mL of sterile, aqueous solution contains: Active: Proparacaine Hydrochloride 5 mg (0.5%). Preservative: Benzalkonium Chloride 0.1 mg (0.01%). Inactives: Glycerin as a stabilizer, Hydrochloric Acid and/or Sodium Hydroxide may be added to adjust pH (3.5 to 6.0), and Water for Injection USP. Proparacaine hydrochloride is designed chemically as 2-(Diethylamino)ethyl 3-amino-4-propoxybenzoate monohydrochloride. The active ingredient is represented by the structural formula: |
|||
Synonyms: | proxymetacaine hydrochloride;Proparacaine Hcl;2-[(3-amino-4-propoxybenzoyl)oxy]-N,N-diethylethanaminium chloride; | ||
Molecular Structure: |